GO-FAR Score for Post-CPR Survival
Predicts neurologically intact survival to hospital discharge after in-hospital CPR. Assists goals-of-care discussions.
Score interpretation
GO-FAR ≤ −6: above-average likelihood (> 15 %) of survival to discharge with good neurological status.
→ Resuscitation is likely to be of benefit; record the patient's wishes.
GO-FAR −5 to 13: average likelihood (3–15 %) of neurologically intact survival after in-hospital arrest.
→ Discuss resuscitation preferences with the patient and family.
GO-FAR 14–23: low likelihood (1–3 %) of neurologically intact survival.
→ Honest goals-of-care discussion; consider the likely outcome of CPR.
GO-FAR ≥ 24: very low likelihood (< 1 %) of neurologically intact survival.
→ Goals-of-care discussion; CPR is very unlikely to achieve a good outcome.
Interpretation bands for the GO-FAR. Apply clinical judgement and local guidance.
References
- Ebell MH et al. The Good Outcome Following Attempted Resuscitation (GO-FAR) Score to Predict Neurologically Intact Survival After In-Hospital Cardiopulmonary Resuscitation. JAMA Intern Med. 2013;173(20):1872-1878.
Related
Curated clinical cross-links plus same-class fallbacks.
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Amiodarone (IV — ICU/Peri-Arrest) · Antiarrhythmic (Class III)
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Clopidogrel (ACS / Post-PCI) · Antiplatelet / ACS
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.